
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Idiopathic pulmonary fibrosis natural history, complications and prognosis
Introduction
Overview
Overview
If left untreated, idiopathic pulmonary fibrosis will lead to respiratory failure and death. Common complications of idiopathic pulmonary fibrosis include pulmonary hypertension, lung cancer, and cardiovascular co-morbidity. The prognosis of idiopathic pulmonary fibrosis is usually poor with a survival rate of 2 to 5 years.
Natural History
Natural History
- If left untreated, idiopathic pulmonary fibrosis will lead to respiratory failure and death.
- The natural progression is different among the patients. Progression may occur in three different forms as the following:[1]
- Some patients may be stable and no significant worsening of respiratory functions be observed
- Other patients’ lung functions get worse over years
- Acute exacerbation of pulmonary fibrosis may be seen after disease stability
Complications
Complications
- Common complications of idiopathic pulmonary fibrosis include the following:[2]
- Pulmonary hypertension: Around 30% of IPF patients are complicated by pulmonary hypertension.
- Lung cancer
- Cardiovascular comorbidity
- Obstructive sleep apnea
- Combined pulmonary fibrosis and emphysema
Prognosis
Prognosis
- The prognosis of idiopathic pulmonary fibrosis is usually poor with a survival rate of 2 to 5 years.
References
References
- ↑ Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK; et al. (2011). “An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management”. Am J Respir Crit Care Med. 183 (6): 788–824. doi:10.1164/rccm.2009-040GL. PMC 5450933. PMID 21471066. Review in: Ann Intern Med. 2011 Jun 21;154(12):JC6-8
- ↑ Raghu G, Amatto VC, Behr J, Stowasser S (2015). “Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review”. Eur Respir J. 46 (4): 1113–30. doi:10.1183/13993003.02316-2014. PMID 26424523.
[[Category:Primary Care]
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
